Cargando…
Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report
IMPORTANCE: There is a need for validated clinical end points that are reliably able to quantify potential therapeutic effects of future treatments targeting age-related macular degeneration (AMD) before the onset of serious visual impairment. OBJECTIVE: To assess the reliability and discriminatory...
Autores principales: | Dunbar, Hannah M. P., Behning, Charlotte, Abdirahman, Amina, Higgins, Bethany E., Binns, Alison M., Terheyden, Jan H., Zakaria, Nadia, Poor, Stephen, Finger, Robert P., Leal, Sergio, Holz, Frank G., Schmid, Matthias, Crabb, David P., Rubin, Gary S., Luhmann, Ulrich F. O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227684/ https://www.ncbi.nlm.nih.gov/pubmed/35737401 http://dx.doi.org/10.1001/jamaophthalmol.2022.2113 |
Ejemplares similares
-
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration – A MACUSTAR Study Report
por: Higgins, Bethany E., et al.
Publicado: (2023) -
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
por: Terheyden, Jan Henrik, et al.
Publicado: (2023) -
Intersession Repeatability of Structural Biomarkers in Early and Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report
por: Saßmannshausen, Marlene, et al.
Publicado: (2022) -
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR
por: Terheyden, Jan H., et al.
Publicado: (2020) -
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study
por: Terheyden, Jan Henrik, et al.
Publicado: (2021)